About this trial
Using liver biopsy as the gold standard, this study will conduct visual transient elastography (ViTE) examinations using Mindray Hepatus 9 ultrasound diagnostic system in patients with liver injury to evaluate the diagnostic efficacy of Liver Steatosis Analysis (LiSA) and ViTE for grading hepatic steatosis and fibrosis, and establish corresponding diagnostic thresholds.
Eligibility criteria
Qualifiers
Be aged 18-65 years.
Documented liver injury of any etiology with a liver biopsy performed within the past 2 weeks.
Willing to undergo Visual Transient Elastography (ViTE) examination using Mindray Hepatus 9 Ultrasound System and capable of providing written informed consent.
Disqualifiers
Acute viral hepatitis.
Right heart failure with either:Serum transaminases >5× upper limit of normal (ULN),Total bilirubin >85.5 μmol/L.
History of hepatocellular carcinoma (HCC).
Pregnancy.
Trial design
Treatments tested in this trial
- Visual Transient Elastography (ViTE) Examination
Treatment groups
Sponsors and collaborators
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Lead sponsor
Shenzhen Mindray Bio-Medical Electronics Co., Ltd
Collaborator